Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold

View ORCID ProfileM. Gabriela M. Gomes, View ORCID ProfileRicardo Aguas, Jessica G. King, Kate E. Langwig, Caetano Souto-Maior, Jorge Carneiro, Carlos Penha-Gonçalves, Guilherme Gonçalves, Marcelo U. Ferreira
doi: https://doi.org/10.1101/2020.04.27.20081893
M. Gabriela M. Gomes
1Department of Mathematics and Statistics, University of Strathclyde, Glasgow, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for M. Gabriela M. Gomes
  • For correspondence: gabriela.gomes{at}strath.ac.uk
Ricardo Aguas
2Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ricardo Aguas
Jessica G. King
3Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kate E. Langwig
4Department of Biological Sciences, Virginia Tech, Blacksburg, VA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caetano Souto-Maior
5Laboratory of Systems Genetics, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jorge Carneiro
6Instituto Gulbenkian de Ciência, Oeiras, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlos Penha-Gonçalves
6Instituto Gulbenkian de Ciência, Oeiras, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guilherme Gonçalves
7Unidade Multidisciplinar de Investigação Biomédica, Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcelo U. Ferreira
8Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began to spread in late 2019, gradually depleting susceptible populations and causing the incidence of new infections to decline over time. Variation in individual susceptibility or exposure to infection exacerbated this effect. Individuals who were more susceptible or more exposed tended to be infected earlier, depleting the susceptible subpopulation of those who were at higher risk of infection. This selective depletion of susceptibles intensified the deceleration in incidence irrespectively of vaccination programmes. In a theoretical scenario of acquired immunity being long-lasting, susceptible numbers would eventually become low enough to prevent epidemic growth or, in other words, the herd immunity threshold (HIT) would be naturally reached. Early in the coronavirus disease (COVID-19) pandemic, simple calculations, relying on homogeneity assumptions, suggested that herd immunity would require 60-80% of the population to become immune. Here we build, into the underlying models, individual variation in susceptibility or in exposure to infection and demonstrate how that lowers the HIT. Based on data from a variety of sources and early parameter estimates these basic models suggest the HIT associated with natural infection to be in the order of 10-30% for SARS-CoV-2. We discuss how a structure accounting for unobserved selectable variation can be a core feature of infectious disease modelling embedded in model development as reality evolves and complexity is incremented. The goal is to enhance accuracy and enable trade-offs to be adequately addressed in the design of optimal policies.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No external funding was received.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

N/A

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data referred to in the manuscript are publicly available.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted August 01, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold
M. Gabriela M. Gomes, Ricardo Aguas, Jessica G. King, Kate E. Langwig, Caetano Souto-Maior, Jorge Carneiro, Carlos Penha-Gonçalves, Guilherme Gonçalves, Marcelo U. Ferreira
medRxiv 2020.04.27.20081893; doi: https://doi.org/10.1101/2020.04.27.20081893
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold
M. Gabriela M. Gomes, Ricardo Aguas, Jessica G. King, Kate E. Langwig, Caetano Souto-Maior, Jorge Carneiro, Carlos Penha-Gonçalves, Guilherme Gonçalves, Marcelo U. Ferreira
medRxiv 2020.04.27.20081893; doi: https://doi.org/10.1101/2020.04.27.20081893

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (754)
  • Anesthesia (221)
  • Cardiovascular Medicine (3287)
  • Dentistry and Oral Medicine (363)
  • Dermatology (277)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1169)
  • Epidemiology (13354)
  • Forensic Medicine (19)
  • Gastroenterology (898)
  • Genetic and Genomic Medicine (5144)
  • Geriatric Medicine (481)
  • Health Economics (782)
  • Health Informatics (3263)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1189)
  • Hematology (429)
  • HIV/AIDS (1017)
  • Infectious Diseases (except HIV/AIDS) (14619)
  • Intensive Care and Critical Care Medicine (912)
  • Medical Education (476)
  • Medical Ethics (126)
  • Nephrology (522)
  • Neurology (4916)
  • Nursing (262)
  • Nutrition (725)
  • Obstetrics and Gynecology (882)
  • Occupational and Environmental Health (795)
  • Oncology (2518)
  • Ophthalmology (723)
  • Orthopedics (280)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (542)
  • Pediatrics (1299)
  • Pharmacology and Therapeutics (549)
  • Primary Care Research (556)
  • Psychiatry and Clinical Psychology (4202)
  • Public and Global Health (7492)
  • Radiology and Imaging (1704)
  • Rehabilitation Medicine and Physical Therapy (1010)
  • Respiratory Medicine (980)
  • Rheumatology (479)
  • Sexual and Reproductive Health (497)
  • Sports Medicine (424)
  • Surgery (547)
  • Toxicology (72)
  • Transplantation (235)
  • Urology (205)